|
DE19856475A1
(de)
*
|
1998-11-27 |
2000-05-31 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
|
DE10038639A1
(de)
|
2000-07-28 |
2002-02-21 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
|
DE10346940B3
(de)
*
|
2003-10-06 |
2005-06-16 |
Schering Ag |
Substituierte Pentanole, ihre Verwendung zur Herstellung von Arzneimitteln speziell Entzündungshemmer sowie diese enthaltende pharmazeutische Präparate
|
|
EP1373888A2
(en)
*
|
2000-12-28 |
2004-01-02 |
Schering Aktiengesellschaft |
Method for screening for progesterone receptor isoform-specific ligands
|
|
CA2472746A1
(en)
|
2002-01-14 |
2003-07-24 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof
|
|
EP1344776A1
(en)
*
|
2002-03-11 |
2003-09-17 |
Schering Aktiengesellschaft |
5- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -phtalide and 6- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -4-methyl-2,3-benzoxazin-1-one derivatives with progesterone receptor modulating activity for use in fertility control, hormone replacement therapy and the treatment of gynecological disorders
|
|
AU2003209720A1
(en)
*
|
2002-03-11 |
2003-09-22 |
Schering Ag |
5-{2-hydroxy-3-'1-(3-trifluoromethylphenyl)-cyclopropyl!-propionylamino}-phtalide and related compounds with progesterone receptor modulating activity for use in fertility control and hormone replacement therapy
|
|
JP2005521717A
(ja)
|
2002-03-26 |
2005-07-21 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
グルココルチコイドミメチックス、その製造方法、その医薬組成物、及び使用
|
|
DE60318188T2
(de)
|
2002-03-26 |
2008-12-11 |
Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield |
Glucocorticoid-mimetika, deren herstellung, pharmazeutische zusammensetzungen und verwendung
|
|
DE10215316C1
(de)
*
|
2002-04-02 |
2003-12-18 |
Schering Ag |
Chinolin- und Isochinolin-Derivate, ein pharmazeutisches Mittel und ihre Verwendung als Entzündungshemmer
|
|
US7186864B2
(en)
|
2002-05-29 |
2007-03-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
US7074806B2
(en)
|
2002-06-06 |
2006-07-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
WO2004018429A2
(en)
|
2002-08-21 |
2004-03-04 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
KR20050036982A
(ko)
|
2002-08-29 |
2005-04-20 |
베링거 인겔하임 파마슈티칼즈, 인코포레이티드 |
염증, 알러지 및 증식성 질환의 치료에 글루코코르티코이드모사체로 사용하기 위한 3-(설폰아미도에틸)-인돌 유도체
|
|
CA2501867A1
(en)
*
|
2002-10-15 |
2004-04-29 |
James T. Dalton |
Heterocyclic selective androgen receptor modulators and methods of use thereof
|
|
DE10261874A1
(de)
*
|
2002-12-20 |
2004-07-08 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
|
EP1583745A1
(en)
|
2003-01-03 |
2005-10-12 |
Boehringer Ingelheim Pharmaceuticals Inc. |
1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
|
|
US20040224992A1
(en)
*
|
2003-02-27 |
2004-11-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
JP2008529963A
(ja)
*
|
2003-07-01 |
2008-08-07 |
バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト |
複素環式−置換されたペンタノール誘導体類、それらの生成方法及び抗炎症剤としてのそれらの使用
|
|
GB0316290D0
(en)
|
2003-07-11 |
2003-08-13 |
Glaxo Group Ltd |
Novel compounds
|
|
UY28526A1
(es)
|
2003-09-24 |
2005-04-29 |
Boehringer Ingelheim Pharma |
Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
|
|
EP1675839B1
(en)
|
2003-10-16 |
2007-07-11 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
|
|
US7795272B2
(en)
|
2004-03-13 |
2010-09-14 |
Boehringer Ingelheim Pharmaceutical, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
|
|
AR049384A1
(es)
|
2004-05-24 |
2006-07-26 |
Glaxo Group Ltd |
Derivados de purina
|
|
TWI307630B
(en)
|
2004-07-01 |
2009-03-21 |
Glaxo Group Ltd |
Immunoglobulins
|
|
DE102004062182B4
(de)
*
|
2004-12-20 |
2007-06-06 |
Bayer Schering Pharma Ag |
Transdermales Pflaster mit Progesteron A-Spezifische Liganden (PRASL) als Wirkstoff
|
|
ES2326907T3
(es)
|
2004-12-27 |
2009-10-21 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Mimeticos de glucocorticoides, metodos para su preparacion, composiciones farmaceuticas y su uso.
|
|
WO2006072599A2
(en)
|
2005-01-10 |
2006-07-13 |
Glaxo Group Limited |
Androstane 17-alpha carbonate derivatives for use in the treatment of allergic and inflammatory conditions
|
|
JPWO2006083030A1
(ja)
*
|
2005-02-04 |
2008-06-26 |
味の素株式会社 |
脂肪酸の製造方法および脂肪酸の塩結晶
|
|
PE20100737A1
(es)
|
2005-03-25 |
2010-11-27 |
Glaxo Group Ltd |
Nuevos compuestos
|
|
PE20100741A1
(es)
|
2005-03-25 |
2010-11-25 |
Glaxo Group Ltd |
COMPUESTOS DERIVADOS DE 3,4-DIHIDROPIRIMIDO[4,5-d]PIRIMIDIN-2(1H)-ONA COMO INHIBIDORES DE QUINASA p38
|
|
DE102005017326A1
(de)
*
|
2005-04-14 |
2007-03-29 |
Schering Ag |
Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
|
|
US7408060B2
(en)
|
2005-06-24 |
2008-08-05 |
Schering Ag |
Nonsteroidal progesterone receptor modulators
|
|
DE102005030293A1
(de)
*
|
2005-06-24 |
2007-01-04 |
Schering Ag |
Verwendung von nichtsteroidale Progesteronrezeptor-Modulatoren
|
|
DE102005030294A1
(de)
*
|
2005-06-24 |
2007-01-04 |
Schering Ag |
Nichtsteroidale Progesteronrezeptor-Modulatoren
|
|
GB0514809D0
(en)
|
2005-07-19 |
2005-08-24 |
Glaxo Group Ltd |
Compounds
|
|
CN101326169B
(zh)
|
2005-12-09 |
2011-11-16 |
霍夫曼-拉罗奇有限公司 |
作为抗炎剂的糖皮质激素受体调节剂
|
|
TW200730498A
(en)
|
2005-12-20 |
2007-08-16 |
Glaxo Group Ltd |
Compounds
|
|
AU2007242851A1
(en)
|
2006-04-20 |
2007-11-01 |
Glaxo Group Limited |
Novel compounds
|
|
GB0611587D0
(en)
|
2006-06-12 |
2006-07-19 |
Glaxo Group Ltd |
Novel compounds
|
|
BRPI0720131A2
(pt)
|
2006-12-06 |
2014-02-04 |
Boehringer Ingelheim Int |
Glicocorticoides miméticos, métodos para fazê-los, composições farmacêuticas e usos dos mesmos.
|
|
UY30815A1
(es)
*
|
2006-12-21 |
2008-07-31 |
Bayer Schering Pharma Ag |
Moduladores no esteroidales del receptor de progesterona
|
|
UY30805A1
(es)
*
|
2006-12-21 |
2008-07-31 |
Bayer Schering Pharma Ag |
Moduladores no esteroides de receptores de progesterona
|
|
DE102007023614A1
(de)
|
2007-05-21 |
2008-11-27 |
Bayer Schering Pharma Aktiengesellschaft |
Nichtsteroidale Progesteronrezeptor-Modulatoren
|
|
DE102007049630A1
(de)
|
2007-10-11 |
2009-10-29 |
Bayer Schering Pharma Aktiengesellschaft |
Nichtsteroidale Progesteronrezeptor-Modulatoren
|
|
JP5090773B2
(ja)
|
2006-12-26 |
2012-12-05 |
国立大学法人東京工業大学 |
光学活性含フッ素カルボニル−エン生成物の製造方法
|
|
AR065804A1
(es)
|
2007-03-23 |
2009-07-01 |
Smithkline Beecham Corp |
Compuesto de indol carboxamida, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar un medicamento
|
|
DE102007032800A1
(de)
|
2007-07-10 |
2009-01-15 |
Bayer Schering Pharma Aktiengesellschaft |
Nichtsteroidale Progesteronrezeptor-Modulatoren
|
|
DE102007058747A1
(de)
|
2007-12-05 |
2009-06-10 |
Bayer Schering Pharma Aktiengesellschaft |
Nichtsteroidale Progesteronrezeptor-Modulatoren
|
|
EP2070909A1
(de)
*
|
2007-12-15 |
2009-06-17 |
Bayer Schering Pharma AG |
Nichtsteroidale Progesteronrezeptor-Modulatoren
|
|
US20110160249A1
(en)
|
2008-05-23 |
2011-06-30 |
Schaab Kevin Murray |
5-lipoxygenase-activating protein inhibitor
|
|
US8163743B2
(en)
|
2008-06-05 |
2012-04-24 |
GlaxoGroupLimited |
4-carboxamide indazole derivatives useful as inhibitors of PI3-kinases
|
|
ES2383246T3
(es)
|
2008-06-05 |
2012-06-19 |
Glaxo Group Limited |
4-amino-indazoles
|
|
KR20110020902A
(ko)
|
2008-06-06 |
2011-03-03 |
베링거 인겔하임 인터내셔날 게엠베하 |
글루코코르티코이드 유사체, 이의 제조방법, 약제학적 조성물 및 이의 용도
|
|
WO2010094643A1
(en)
|
2009-02-17 |
2010-08-26 |
Glaxo Group Limited |
Quinoline derivatives and their uses for rhinitis and urticaria
|
|
JP5656880B2
(ja)
|
2009-03-09 |
2015-01-21 |
グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ |
Ｐｉ３キナーゼの阻害剤としての４−オキサジアゾール−２−イル−インダゾール
|
|
US8354539B2
(en)
|
2009-03-10 |
2013-01-15 |
Glaxo Group Limited |
Indole derivatives as IKK2 inhibitors
|
|
EP2408769A1
(en)
|
2009-03-17 |
2012-01-25 |
Glaxo Group Limited |
Pyrimidine derivatives used as itk inhibitors
|
|
US20120029054A1
(en)
|
2009-03-19 |
2012-02-02 |
Merck Sharp & Dohme Corp. |
RNA Interference Mediated Inhibition of GATA Binding Protein 3 (GATA3) Gene Expression Using Short Intefering Nucleic Acid (siNA)
|
|
EP2408458A1
(en)
|
2009-03-19 |
2012-01-25 |
Merck Sharp&Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 6 (STAT6) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
|
SG174452A1
(en)
|
2009-03-19 |
2011-10-28 |
Merck Sharp & Dohme |
RNA INTERFERENCE MEDIATED INHIBITION OF BTB AND CNC HOMOLOGY 1, BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR 1 (BACH 1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) SEQUENCE LISTING
|
|
EP2408916A2
(en)
|
2009-03-19 |
2012-01-25 |
Merck Sharp&Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF CONNECTIVE TISSUE GROWTH FACTOR (CTGF) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
|
US20120010272A1
(en)
|
2009-03-27 |
2012-01-12 |
Merck Sharp & Dohme Corp. |
RNA Interference Mediated Inhibition of Apoptosis Signal-Regulating Kinase 1 (ASK1) Gene Expression Using Short Interfering Nucleic Acid (siNA)
|
|
CN102439152A
(zh)
|
2009-03-27 |
2012-05-02 |
默沙东公司 |
使用短干扰核酸（siNA）的RNA干扰介导的细胞间粘附分子1（ICAM-1）基因表达的抑制
|
|
WO2010111468A2
(en)
|
2009-03-27 |
2010-09-30 |
Merck Sharp & Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF THE NERVE GROWTH FACTOR BETA CHAIN (NGFß) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)
|
|
WO2010111471A2
(en)
|
2009-03-27 |
2010-09-30 |
Merck Sharp & Dohme Corp. |
RNA INTERFERENCE MEDIATED INHIBITION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1 (STAT1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
|
US20120022143A1
(en)
|
2009-03-27 |
2012-01-26 |
Merck Sharp & Dohme Corp |
RNA Interference Mediated Inhibition of the Thymic Stromal Lymphopoietin (TSLP) Gene Expression Using Short Interfering Nucliec Acid (siNA)
|
|
US20120035237A1
(en)
|
2009-04-24 |
2012-02-09 |
Diane Mary Coe |
Pyrazole and triazole carboxamides as crac chann el inhibitors
|
|
EP2421835A1
(en)
|
2009-04-24 |
2012-02-29 |
Glaxo Group Limited |
N-pyrazolyl carboxamides as crac channel inhibitors
|
|
MY160454A
(en)
|
2009-04-30 |
2017-03-15 |
Glaxo Group Ltd |
Oxazole substituted indazoles as pi3-kinase inhibitors
|
|
WO2011067364A1
(en)
|
2009-12-03 |
2011-06-09 |
Glaxo Group Limited |
Novel compounds
|
|
WO2011067366A1
(en)
|
2009-12-03 |
2011-06-09 |
Glaxo Group Limited |
Indazole derivatives as pi 3 - kinase inhibitors
|
|
US20120245171A1
(en)
|
2009-12-03 |
2012-09-27 |
Glaxo Group Limited |
Benzpyrazole derivatives as inhibitors of pi3 kinases
|
|
US20120272951A1
(en)
|
2009-12-16 |
2012-11-01 |
3M Innovative Properties Company |
Formulations and methods for controlling mdi particle size delivery
|
|
WO2011110575A1
(en)
|
2010-03-11 |
2011-09-15 |
Glaxo Group Limited |
Derivatives of 2-[2-(benzo- or pyrido-) thiazolylamino]-6-aminopyridine, useful in the treatment of respiratoric, allergic or inflammatory diseases
|
|
GB201007203D0
(en)
|
2010-04-29 |
2010-06-16 |
Glaxo Group Ltd |
Novel compounds
|
|
DK2614058T3
(en)
|
2010-09-08 |
2015-09-28 |
Glaxosmithkline Ip Dev Ltd |
Polymorphs, and the salts of N- [5- [4- (5 - {[(2R, 6S) -2,6-dimethyl-4-morpholinyl] methyl} -1,3-oxazol-2-yl) -1H-indazole -6-yl] -2- (methyloxy) -3-pyridinyl] methanesulfonamide.
|
|
US9326987B2
(en)
|
2010-09-08 |
2016-05-03 |
Glaxo Group Limited |
Indazole derivatives for use in the treatment of influenza virus infection
|
|
WO2012035055A1
(en)
|
2010-09-17 |
2012-03-22 |
Glaxo Group Limited |
Novel compounds
|
|
US9149462B2
(en)
|
2010-10-21 |
2015-10-06 |
Glaxo Group Limited |
Pyrazole compounds acting against allergic, inflammatory and immune disorders
|
|
ES2532213T3
(es)
|
2010-10-21 |
2015-03-25 |
Glaxo Group Limited |
Compuestos de pirazol que actúan contra afecciones alérgicas, inmunitarias e inflamatorias
|
|
GB201018124D0
(en)
|
2010-10-27 |
2010-12-08 |
Glaxo Group Ltd |
Polymorphs and salts
|
|
GB201104153D0
(en)
|
2011-03-11 |
2011-04-27 |
Glaxo Group Ltd |
Novel compounds
|
|
WO2012123312A1
(en)
|
2011-03-11 |
2012-09-20 |
Glaxo Group Limited |
Pyrido[3,4-b]pyrazine derivatives as syk inhibitors
|
|
CA2918938C
(en)
|
2013-09-22 |
2021-05-18 |
Calitor Sciences, Llc |
Substituted aminopyrimidine compounds and methods of use
|
|
RU2016112268A
(ru)
|
2013-10-17 |
2017-11-22 |
Глаксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед |
Ингибитор PI3K для лечения респираторного заболевания
|
|
AU2014336251A1
(en)
|
2013-10-17 |
2016-04-14 |
Glaxosmithkline Intellectual Property Development Limited |
PI3K inhibitor for treatment of respiratory disease
|
|
WO2015148868A1
(en)
|
2014-03-28 |
2015-10-01 |
Calitor Sciences, Llc |
Substituted heteroaryl compounds and methods of use
|
|
EA201692111A1
(ru)
|
2014-05-12 |
2017-08-31 |
Глаксосмитклайн Интеллекчуал Проперти (№ 2) Лимитед |
Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний
|
|
WO2017044434A1
(en)
|
2015-09-11 |
2017-03-16 |
Sunshine Lake Pharma Co., Ltd. |
Substituted heteroaryl compounds and methods of use
|
|
GB201602527D0
(en)
|
2016-02-12 |
2016-03-30 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
|
WO2018029126A1
(en)
|
2016-08-08 |
2018-02-15 |
Glaxosmithkline Intellectual Property Development Limited |
Chemical compounds
|
|
GB201706102D0
(en)
|
2017-04-18 |
2017-05-31 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
|
GB201712081D0
(en)
|
2017-07-27 |
2017-09-13 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
|
EP3569228A1
(en)
*
|
2018-05-17 |
2019-11-20 |
Association pour la recherche à l'IGBMC (ARI) |
Non-steroidal selective glucocorticoid receptor agonistic modulators (segrams) and uses thereof
|
|
EP3710006A4
(en)
|
2017-11-19 |
2021-09-01 |
Sunshine Lake Pharma Co., Ltd. |
SUBSTITUTED HETEROARYL COMPOUNDS AND THEIR METHODS OF USE
|
|
WO2019143874A1
(en)
|
2018-01-20 |
2019-07-25 |
Sunshine Lake Pharma Co., Ltd. |
Substituted aminopyrimidine compounds and methods of use
|
|
JP2023519585A
(ja)
|
2020-03-26 |
2023-05-11 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド |
ウイルス感染を予防または治療するカテプシン阻害剤
|
|
CN116082311B
(zh)
*
|
2020-06-12 |
2025-04-25 |
上海济煜医药科技有限公司 |
酞嗪酮类化合物及其制备方法和医药用途
|
|
CN114605308B
(zh)
*
|
2022-03-18 |
2023-12-19 |
阜新孚隆宝医药科技有限公司 |
一种帕罗韦德的氮杂双环医药中间体的制备方法及中间体
|